196 related articles for article (PubMed ID: 7542417)
1. Identification of a linear neutralization domain in the protein VP2 of African horse sickness virus.
Martínez-Torrecuadrada JL; Casal JI
Virology; 1995 Jul; 210(2):391-9. PubMed ID: 7542417
[TBL] [Abstract][Full Text] [Related]
2. Antigenic profile of African horse sickness virus serotype 4 VP5 and identification of a neutralizing epitope shared with bluetongue virus and epizootic hemorrhagic disease virus.
Martínez-Torrecuadrada JL; Langeveld JP; Venteo A; Sanz A; Dalsgaard K; Hamilton WD; Meloen RH; Casal JI
Virology; 1999 May; 257(2):449-59. PubMed ID: 10329555
[TBL] [Abstract][Full Text] [Related]
3. Expression and characterization of the two outer capsid proteins of African horsesickness virus: the role of VP2 in virus neutralization.
Martinez-Torrecuadrada JL; Iwata H; Venteo A; Casal I; Roy P
Virology; 1994 Jul; 202(1):348-59. PubMed ID: 8009847
[TBL] [Abstract][Full Text] [Related]
4. Protective immunization of horses with a recombinant canarypox virus vectored vaccine co-expressing genes encoding the outer capsid proteins of African horse sickness virus.
Guthrie AJ; Quan M; Lourens CW; Audonnet JC; Minke JM; Yao J; He L; Nordgren R; Gardner IA; Maclachlan NJ
Vaccine; 2009 Jul; 27(33):4434-8. PubMed ID: 19490959
[TBL] [Abstract][Full Text] [Related]
5. Neutralizing epitopes of African horsesickness virus serotype 4 are located on VP2.
Burrage TG; Trevejo R; Stone-Marschat M; Laegreid WW
Virology; 1993 Oct; 196(2):799-803. PubMed ID: 7690505
[TBL] [Abstract][Full Text] [Related]
6. Cloning, characterization and expression of the gene that encodes the major neutralization-specific antigen of African horsesickness virus serotype 3.
Vreede FT; Huismans H
J Gen Virol; 1994 Dec; 75 ( Pt 12)():3629-33. PubMed ID: 7996157
[TBL] [Abstract][Full Text] [Related]
7. Definition of neutralizing sites on African horse sickness virus serotype 4 VP2 at the level of peptides.
Martínez-Torrecuadrada JL; Langeveld JPM; Meloen RH; Casal JI
J Gen Virol; 2001 Oct; 82(Pt 10):2415-2424. PubMed ID: 11562535
[TBL] [Abstract][Full Text] [Related]
8. Identification of antigenic regions on VP2 of African horsesickness virus serotype 3 by using phage-displayed epitope libraries.
Bentley L; Fehrsen J; Jordaan F; Huismans H; du Plessis DH
J Gen Virol; 2000 Apr; 81(Pt 4):993-1000. PubMed ID: 10725425
[TBL] [Abstract][Full Text] [Related]
9. Vaccination with recombinant Modified Vaccinia Ankara (MVA) viruses expressing single African horse sickness virus VP2 antigens induced cross-reactive virus neutralising antibodies (VNAb) in horses when administered in combination.
Manning NM; Bachanek-Bankowska K; Mertens PPC; Castillo-Olivares J
Vaccine; 2017 Oct; 35(44):6024-6029. PubMed ID: 28438410
[TBL] [Abstract][Full Text] [Related]
10. Recombinant baculovirus-synthesized African horsesickness virus (AHSV) outer-capsid protein VP2 provides protection against virulent AHSV challenge.
Roy P; Bishop DH; Howard S; Aitchison H; Erasmus B
J Gen Virol; 1996 Sep; 77 ( Pt 9)():2053-7. PubMed ID: 8811002
[TBL] [Abstract][Full Text] [Related]
11. Preparation of recombinant African horse sickness virus VP7 antigen via a simple method and validation of a VP7-based indirect ELISA for the detection of group-specific IgG antibodies in horse sera.
Maree S; Paweska JT
J Virol Methods; 2005 Apr; 125(1):55-65. PubMed ID: 15737417
[TBL] [Abstract][Full Text] [Related]
12. Antigenic sites on the receptor-binding domain of human adenovirus type 2 fiber.
Fender P; Kidd AH; Brebant R; Oberg M; Drouet E; Chroboczek J
Virology; 1995 Dec; 214(1):110-7. PubMed ID: 8525605
[TBL] [Abstract][Full Text] [Related]
13. Immunization with VP2 is sufficient for protection against lethal challenge with African horsesickness virus Type 4.
Stone-Marschat MA; Moss SR; Burrage TG; Barber ML; Roy P; Laegreid WW
Virology; 1996 Jun; 220(1):219-22. PubMed ID: 8659117
[TBL] [Abstract][Full Text] [Related]
14. Mapping of epitopes of VP2 protein of chicken anemia virus using monoclonal antibodies.
Wang X; Gao H; Gao Y; Fu C; Wang Z; Lu G; Cheng Y; Wang X
J Virol Methods; 2007 Aug; 143(2):194-9. PubMed ID: 17481740
[TBL] [Abstract][Full Text] [Related]
15. VP2 Exchange and NS3/NS3a Deletion in African Horse Sickness Virus (AHSV) in Development of Disabled Infectious Single Animal Vaccine Candidates for AHSV.
van de Water SG; van Gennip RG; Potgieter CA; Wright IM; van Rijn PA
J Virol; 2015 Sep; 89(17):8764-72. PubMed ID: 26063433
[TBL] [Abstract][Full Text] [Related]
16. Antigenic epitopes of the hepatitis A virus polyprotein.
Khudyakov YE; Lopareva EN; Jue DL; Fang S; Spelbring J; Krawczynski K; Margolis HS; Fields HA
Virology; 1999 Aug; 260(2):260-72. PubMed ID: 10417261
[TBL] [Abstract][Full Text] [Related]
17. Production and characterization of murine IgA monoclonal antibodies to the surface antigens of rhesus rotavirus.
Giammarioli AM; Mackow ER; Fiore L; Greenberg HB; Ruggeri FM
Virology; 1996 Nov; 225(1):97-110. PubMed ID: 8918537
[TBL] [Abstract][Full Text] [Related]
18. Development of HIV/AIDS vaccine using chimeric gag-env virus-like particles.
Kang CY; Luo L; Wainberg MA; Li Y
Biol Chem; 1999 Mar; 380(3):353-64. PubMed ID: 10223338
[TBL] [Abstract][Full Text] [Related]
19. Identification and localization of a serotypic neutralization determinant on the VP2 protein of bluetongue virus 13.
Hwang GY; Li JK
Virology; 1993 Aug; 195(2):859-62. PubMed ID: 7687805
[TBL] [Abstract][Full Text] [Related]
20. Characterization of epitopes for virus-neutralizing monoclonal antibodies to Ross River virus E2 using phage-displayed random peptide libraries.
Davies JM; Cai YP; Weir RC; Rowley MJ
Virology; 2000 Sep; 275(1):67-76. PubMed ID: 11017788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
